Misra Rashmi, Toprani Nikita, Bhagwat Sumita, Vaishnav Aashaka, Dureja Aastha, Bhosale Omkar
Department of Conservative Dentistry and Endodontics, DY Patil School of Dentistry, Navi Mumbai, IND.
Cureus. 2025 Jul 31;17(7):e89154. doi: 10.7759/cureus.89154. eCollection 2025 Jul.
The present systematic review and meta-analysis aimed to evaluate and compare the clinical efficacy of Mineral Trioxide Aggregate (MTA) and Biodentine (BD) as direct pulp capping materials in cariously exposed mature permanent teeth, focusing on outcomes such as pulp vitality preservation, dentin bridge formation, and complication rates, including tooth discoloration. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and other dental databases following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The review protocol was registered in PROSPERO (CRD42023463513). Eligible studies included randomized controlled trials and retrospective studies reporting clinical and radiographic success. Risk of bias was assessed using the Cochrane Risk of Bias Tool and the Newcastle-Ottawa Scale. Eleven studies involving 373 treated teeth were included. Meta-analysis revealed a pooled risk ratio (RR) for success of 0.98 (95% CI: 0.94-1.03), slightly favoring MTA but without statistical significance. BD showed a lower failure rate (RR = 1.94; 95% CI: 0.48-7.94) and marginally better outcomes in calcific bridge formation (RR = 0.90; 95% CI: 0.75-1.08), though these differences were also not statistically significant. Biodentine demonstrated superior handling, a shorter setting time (about 12 minutes), and no risk of discoloration, which is an issue noted with MTA. Both materials are clinically effective, but BD may be preferable due to its practical and aesthetic advantages. Further long-term, standardized studies are recommended.
本系统评价和荟萃分析旨在评估和比较三氧化矿物凝聚体(MTA)和生物活性玻璃(BD)作为直接盖髓材料用于龋源性暴露的成熟恒牙的临床疗效,重点关注牙髓活力保存、牙本质桥形成以及包括牙齿变色在内的并发症发生率等结果。按照系统评价和荟萃分析的首选报告项目(PRISMA)指南,在PubMed、Scopus、Web of Science和其他牙科数据库中进行了全面的文献检索。该评价方案已在PROSPERO(CRD42023463513)中注册。符合条件的研究包括报告临床和影像学成功的随机对照试验和回顾性研究。使用Cochrane偏倚风险工具和纽卡斯尔-渥太华量表评估偏倚风险。纳入了11项涉及373颗治疗牙齿的研究。荟萃分析显示成功的合并风险比(RR)为0.98(95%CI:0.94-1.03),略倾向于MTA,但无统计学意义。BD显示出较低的失败率(RR = 1.94;95%CI:0.48-7.94),在钙化桥形成方面的结果略好(RR = 0.90;95%CI:0.75-1.08),尽管这些差异也无统计学意义。生物活性玻璃表现出更好的操作性、更短的凝固时间(约12分钟),且不存在牙齿变色风险,而这是MTA存在的一个问题。两种材料在临床上均有效,但由于其实际和美学优势,BD可能更可取。建议进一步开展长期、标准化的研究。